Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide).
about
Concordant association validates MGMT methylation and protein expression as favorable prognostic factors in glioma patients on alkylating chemotherapy (Temozolomide).
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Concordant association validat ...... g chemotherapy (Temozolomide).
@en
Concordant association validat ...... nts on alkylating chemotherapy
@nl
type
label
Concordant association validat ...... g chemotherapy (Temozolomide).
@en
Concordant association validat ...... nts on alkylating chemotherapy
@nl
prefLabel
Concordant association validat ...... g chemotherapy (Temozolomide).
@en
Concordant association validat ...... nts on alkylating chemotherapy
@nl
P2093
P2860
P1433
P1476
Concordant association validat ...... g chemotherapy (Temozolomide).
@en
P2093
Abdul R Bhat
Arshad A Pandith
Dheera Sanadhya
Iqbal Qasim
Niyaz A Naikoo
Parveen Shah
Wani Zahoor
Zafar A Shah
P2860
P356
10.1038/S41598-018-25169-2
P407
P577
2018-04-30T00:00:00Z